Roche’s MabTherea shot gets EU OK for chronic lymphocytic leukemia
The European Commission approved the injection for people with previously untreated and relapsed/refractory forms of the disease.
“MabThera SC provides patients with significantly faster treatment administration and the opportunity to enjoy more time outside the clinical setting compared to intravenous delivery of the medicine,” Chief Medical Officer Sandra Horning said.
(Reporting by Brenna Hughes Neghaiwi; Editing by Michael Shields)
Source: Reuters Health